Tag: Spring 2018
Japan’s wave of governance reform is welcomed, and isn’t over yet
Abenomics—or “Japan’s Revitalisation Strategy”—is awakening the concept of investor stewardship and focusing the minds of Japan’s corporate elite on how to improve governance standards.
Why serious investors demand more than just climate disclosure
Investors serious about climate change cannot settle for disclosure; their attention must now be on action, writes Sophia McNab of investment charity ShareAction.
Cybersecurity is a key corporate governance concern
The security of a company’s data is no longer an IT issue but a key concern for corporate governance, writes Fiona Reynolds of the UN Principles for Responsible Investment.
Remcos must be reformed to reign in executive pay
If executive pay is to be brought under control, a different approach will be needed for remuneration committees and strategic planning.
Research reveals executives’ views on the ethics of high pay
It is now widely recognised that there has been an exceptional increase in executive pay over the past 30 years. But recent academic research asked executives: is it right and fair that some people earn disproportionately more than others?
An asset to responsible investment: Michael Herskovich, BNP Paribas
Michael Herskovich, head of corporate governance at BNP Paribas Asset Management, tells Board Agenda how sustainability is central to its values, and why it is engaging with others to follow suit.
How business can recognise the true value of people and communities
The new Social & Human Capital Coalition will help make business more successful and society more resilient, argues Peter Bakker.
Buyback mountain: why the rise in share buybacks is causing concern
The number of share buybacks is mounting and the UK is concerned that they may happen to be boosting executive pay. Board Agenda considers the arguments for and against share buybacks.
Culture at heart: Steven Baert, Novartis
Steven Baert, the group head of human resources at Novartis, explores the thinking behind culture change at the Swiss pharmaceuticals behemoth.
The audit market concentration ratchet strengthens case for reform
The audit market is being accused of lacking competition, but there is a case for reforming ownership rules.